FORT WORTH, TEXAS (April 3, 2018) – Bartell Drugs, a family-owned pharmacy with more than 60 locations in Washington and Oregon, will use Buxton’s data analytics to confidently prioritize and evaluate new locations for expansion within the region.
“Bartell Drugs has grown a large presence since its beginnings in 1890,” said Tim White, senior vice president of Buxton. “Buxton is excited to provide the insights needed for the organization to make confident expansion decisions.”
As a Buxton client, Bartell Drugs will have access to the web-based Buxton Analytics Platform, which will allow Bartell Drugs to score potential sites, visualize market data and run reports to support its growth strategy. Bartell Drugs joins a growing list of organizations using the Buxton Analytics Platform as a pre-screening tool for real estate location and market planning decisions.
Buxton is the industry leader in customer analytics. Our analytics reveal who your customers are, where more potential customers are located and the value of each customer. More than 4,000 clients in the retail, restaurant, healthcare, private equity, and public sectors have relied on our insights to guide their growth strategies.
For more information, visit www.buxtonco.com.